Israeli Oral COVID-19 Vaccine Booster Proves Effective In Preclinical Trials nocamels.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from nocamels.com Daily Mail and Mail on Sunday newspapers.
Scopus BioPharma soars on FDA approval
At one stage in yesterday s session, Scopus Biopharma s share price was up 100%. It closed up nearly 80%.
Drug company Scopus BioPharma Inc. (Nasdaq: SCPS), has reported that the US Food and Drug Administration (FDA) has approved the start of a clinical trial for the company s RNA cancer therapy (CpG-STAT3siRNA), developed in cooperation with the City of Hope hospital in California. A Phase 1 clinical trial for B-cell non-Hodgkin lymphoma will be initiated at City of Hope.
At one stage in yesterday s session, Scopus Biopharma s share price was up 100%. It closed up nearly 80%.
Scopus BioPharma has an Israeli connection in that one of its founders, Dr. Morris Laster is an American-Israeli. Laster has over 30 years experience in the drugs industry, and in the past he founded, or co-founded, and managed companies such as BioLineRx Ltd. (Nasdaq: BLRX), Keryx Biopharmaceuticals, merged in December 2018 with Akebia Therapeutics, Inc. (Nasdaq: AKB